The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,450,742 A shares and 108,683,536 B shares. The number of votes of the company's shares is ...

Jean-Paul Clozel, Chairman of the Board of Idorsia, commented: “The team at Idorsia continues to go the extra mile to secure the company’s future. I would like to thank my colleagues on the Board for ...

D-Bal MAX is a revolutionary new muscle-building supplement that will put you on the fast track to building lean muscle and ...

Tallmadge, Ohio, May 01, 2025 (GLOBE NEWSWIRE) -- Following Over 90 Days of Personal Experience, Here’s What Truly Occurred ...

Comprehensive Healthcare today announced the expansion of its permanent supportive housing program in Sunnyside with the opening of Vista Del Sol-2 (VDS-2), a 20-unit long-term residential housing ...

CONCORD, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) ("Ultrack" or the "Company") is pleased to announce it has entered into a Memorandum of Understanding (MOU) to ...

The Hats On Challenge provides an opportunity to take part in raising awareness of AK. Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. If left untreated, AK ...

Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference or contact [email protected]. About Genelux Corporation Genelux is a late ...

CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac ...

Chairman/CEO George LeMaitre said, “Q1 sales momentum allows us to increase our 2025 reported ($245mm) and organic (+13%) sales guidance, up from prior guidance of $239mm and 10%. $303mm of cash also ...

Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the ...

Webcasts of the presentations will be accessible through the News & Events page of the Investor Relations section of the Company’s website at www.sutrobio.com. Archived replays will be available for ...